Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinapril and Losartan in Diabetic Autonomic Neuropathy (DANEL)
NCT05713396Phase 4Completed
- Sponsor
- AHEPA University Hospital
- Start
- Jan 2017
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quinapril, losartan in diabetic autonomic neuropathy (DAN), left ventricular dysfunction, sponsored by AHEPA University Hospital. Started Jan 2017; status: completed.
02
Drugs
quinaprillosartan
03
Conditions
diabetic autonomic neuropathy (DAN)left ventricular dysfunction
Beyond the preview
Go deeper on NCT05713396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05713396.